PNTG · NASDAQ · Medical - Care Facilities

The Pennant Group (PNTG)

Runs decentralized home health, hospice, home care, and senior living operations.

$39.43
vs last close+0.02 (+0.05%)
Loading prices…

The Pennant Group, Inc.PNTG
Health Care

Provides home health, hospice, home care, geriatric primary and palliative care, and senior living services through local operating subsidiaries. Most revenue comes from home health and hospice, with growth tied to acquisitions, census and occupancy gains, reimbursement, and staffing.

Runs home health, hospice, home care, geriatric primary and palliative care, and senior living services across a U.S. operating footprint. Home health and hospice provide most revenue, while senior living adds assisted living, independent living, and memory care communities.

Operates as a holding company over independent local subsidiaries, with a central Service Center supporting accounting, payroll, human resources, IT, legal, risk, and compliance. The model relies on local leaders, cluster-level support, and acquisitions alongside census and occupancy growth.

Started public life as a 2019 Ensign Group spin-off. Medicare and Medicaid reimbursement, caregiver availability, acquisition competition, and senior-living occupancy shape the business.

Company facts

CEOBrent J. Guerisoli
ListedOct 1, 2019
ExchangeNASDAQ
HeadquartersEagle, ID
CountryUnited States
Employees9,700
CIK0001766400
ISINUS70805E1091

Market cap$1.37B
EPS (ttm)$0.9000
P/E (ttm)43.79
ROE9.5%
P/B3.81
P/S1.24
Dividend yieldDiv yield
Beta0.22vs XLV 0.68

Price target$45.00+14.2%Average of 7 analysts
ConsensusBuy6 of 7 analysts
Ratings

Target rangeAs of Sep 22, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 20, 2026RBC CapitalReiterate
Rating: Target: $39
Rating: OutperformTarget: $44
Aug 11, 2026Wells FargoReiterate
Rating: Target: $45
Rating: OverweightTarget: $46
Jul 14, 2026Truist FinancialTarget
Target: $34
Target: $48
Jul 13, 2026Wells FargoReiterate
Rating: Target: $38
Rating: OverweightTarget: $45
May 8, 2026OppenheimerTarget
Target:
Target: $40

Next report
Nov 4, 26
in 42 days
EPS estimate
$0.33
Revenue estimate
$299.3M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.24$0.27$0.27$0.30$0.34$0.32$0.36Pending
Estimate$0.24$0.22$0.26$0.29$0.31$0.31$0.33$0.33
Surprise0.0%+22.7%+3.8%+3.4%+9.7%+3.2%+8.6%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$188.9M$209.8M$219.5M$229.0M$289.3M$285.4M$298.0MPending
Estimate$185.8M$201.5M$214.6M$275.2M$275.2M$280.7M$288.7M$299.3M
Surprise+1.6%+4.2%+2.3%−16.8%+5.1%+1.6%+3.2%
Estimate$0.33
ReportedDue Nov 4, 2026
Estimate$299.3M
ReportedDue Nov 4, 2026
View details

Debt to equity137.50%
Current ratio120.50%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$180.7M$188.9M$209.8M$219.5M$229.0M$289.3M$285.4M$298.0M
Net income$6.2M$5.8M$7.8M$7.1M$6.1M$8.6M$8.5M$9.1M
Net margin3.4%3.0%3.7%3.2%2.7%3.0%3.0%3.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$10.8M$9.2M$12.7M$11.5M$10.2M$18.1M$18.1M$17.2M
YoY growth+52.9%+22.1%+48.4%+20.6%−5.2%+95.7%+42.8%+49.1%

Balance sheet, Jun 30, 2026Cash & short-term investments $15.3M · Total debt $493.9M · Total assets $1.04B · Shareholders' equity $359.2M

Revenue
$298.0M
Operating income
$17.2M
Net income
$9.1M
View details

No dividends on record.

Institutions91.51%31.96M shares
205 holders · as of Jun 30, 2026
Insiders3.19%1.11M shares
13 holders · as of Aug 10, 2026
Strategic holders11.86%4.14M shares
1 holder · as of Jan 27, 2022
Adds to106.56%

34.93M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

These groups come from separate filings that can overlap, so they add to 106.56%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Strategic
11.86%4.14Mfiled Jan 27, 2022
T. Rowe Price Investment Management, Inc.Institution
11.39%3.98Mfiled Aug 10, 2022
BlackRock, Inc.Institution
8.47%2.96Mas of Jun 30, 2026
Van Berkom & Associates Inc.Institution
6.78%2.37Mas of Jun 30, 2026
Wasatch Advisors LPInstitution
5.35%1.87Mas of Jun 30, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Aug 6, 2026Jason Paul Steikofficer: Chief Clinical Officer−1,394$38.52
Aug 6, 2026Brent Guerisoliofficer: Chief Executive Officer−4,285$38.52
Aug 6, 2026Kirk Sterling Cheneyofficer: EVP, GC and Corp Secy−1,393$38.52
Jul 10, 2026Brent Guerisoliofficer: Chief Executive Officer−3,159$41.57
Jul 7, 2026Brent Guerisoliofficer: Chief Executive Officer−3,165$40.51
View details

Compare

CompanyPriceChange
The Pennant Group$39.43+0.05%$1.37B43.827.21.2+35.8%
Addus HomeCare$114.98+0.65%$2.13B20.016.01.4+8.0%
BrightSpring Health Services$56.17−0.67%$11.10B42.227.50.8+23.0%
National HealthCare$223.99+0.51%$3.48B25.12.2+9.4%
Chemed$499.42+0.56%$6.49B24.919.42.5+8.8%
Brookdale Senior Living$11.24−1.36%$2.72B518.50.9−11.6%
The Ensign Group$176.19−0.08%$10.28B27.621.51.9+17.3%
Aveanna Healthcare$12.94−2.16%$2.88B10.515.11.1+13.7%
Median25.020.51.4+9.4%